Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy
Open Access
- 1 December 1980
- Vol. 46 (11) , 2380-2388
- https://doi.org/10.1002/1097-0142(19801201)46:11<2380::aid-cncr2820461113>3.0.co;2-m
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Combination chemotherapy for advanced breast cancer utilizing vincristine, adriamycin, and cyclophosphamide (VAC)Cancer, 1979
- Comparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancerCancer, 1979
- Estrogen Receptors and Responses to Chemotherapy and Hormonal Therapy in Advanced Breast CancerNew England Journal of Medicine, 1978
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- The Relation between Estrogen Receptors and Response Rate to Cytotoxic Chemotherapy in Metastatic Breast CancerNew England Journal of Medicine, 1978
- Prognostic Factors in the Initial Response to Therapy by Patients With Advanced Breast Cancer 2JNCI Journal of the National Cancer Institute, 1978
- Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancerCancer, 1975
- A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorshipBiometrika, 1970
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958